Also trades as: 0HX7.L (LSE) · $vol 0M
ACET NASDAQ
Adicet Bio, Inc.
1W: -27.9%
1M: -29.8%
3M: -28.3%
YTD: -26.3%
1Y: -50.6%
3Y: -71.8%
5Y: -94.7%
$6.50
-0.14 (-2.11%)
Weekly Expected Move ±18.7%
$4
$5
$6
$8
$9
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (25)
Is Tenet Healthcare (THC) Outperforming Other Medical Stocks This Year?
Wall Street Analysts See a 258.21% Upside in Adicet Bio (ACET): Can the Stock Really Move This High?
Is Adicet Bio (ACET) Outperforming Other Medical Stocks This Year?
Johnson & Johnson Owns Stakes in 15 Stocks. Here's the Best of the Bunch.
Here's Why You Should Add ACET Stock to Your Portfolio Now
Are Medical Stocks Lagging Adicet Bio (ACET) This Year?
Wall Street Analysts Think Adicet Bio (ACET) Could Surge 301.57%: Read This Before Placing a Bet
All You Need to Know About Adicet Bio (ACET) Rating Upgrade to Buy
Is Adicet Bio (ACET) Stock Outpacing Its Medical Peers This Year?
10 Health Care Stocks Moving In Monday's Pre-Market Session
Are Medical Stocks Lagging Adicet Bio (ACET) This Year?
Wall Street Analysts Believe Adicet Bio (ACET) Could Rally 319.64%: Here's is How to Trade
Adicet Bio (ACET) Upgraded to Buy: Here's Why
Adicet Bio GAAP EPS of -$2.94
Adicet Bio, Inc. (NASDAQ:ACET) Receives $69.00 Consensus PT from Brokerages
Adicet Bio to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
Adicet Bio (NASDAQ:ACET) Shares Pass Below 200-Day Moving Average – What’s Next?
Adicet Bio, Inc. (NASDAQ:ACET) Short Interest Down 95.7% in December
Adicet Bio (NASDAQ:ACET) Stock Passes Below Two Hundred Day Moving Average – Should You Sell?
Adicet Bio Provides Corporate Update and Highlights Expected 2026 Milestones
Adicet Bio, Inc. (NASDAQ:ACET) Short Interest Update
Adicet Bio Announces Reverse Stock Split
Adicet Bio (NASDAQ:ACET) Shares Cross Below Two Hundred Day Moving Average – Time to Sell?
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Brokerages Set Adicet Bio, Inc. (NASDAQ:ACET) PT at $7.33